Cervical Cancer Screening



The ThinPrep Pap Test and the ThinPrep Imaging System combine to create more accurate and comprehensive cervical cancer screening — giving added confidence in the results. In addition, ThinPrep is the only liquid-based Pap test FDA approved/cleared for HPV, Chlamydia/Gonorrhea and Trichomonas testing straight from the vial.

Click for more information


Cervista HPV:              

The Cervista HPV test is the first FDA-approved high-risk HPV test designed to detect all 14 oncogenic strains of HPV, with 100% detection rate of CIN3+ and a 99.1% negative predictive value for CIN2+.

Click for more information


Aptima HPV Assays:

The latest addition to Hologic Gen-Probe’s menu of women’s health test options, The APTIMA HPV assay is an in vitro nucleic acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of HPV in cervical specimens and accurately detects the HPV types likely to progress to cancer.

Click for more information

inforgraphic hpv+pap

Lead Author Discusses Cervical Cancer Screening Study:

Click below to access the exclusive interview with study author Dr. R. Marshall Austin and related infographic

Click for more information

Webinar: Improving Cervical Cytology Collection Techniques to Improve Accuracy

Dr. J. Craig Strafford provides an overview of proper cervical collection technique, clinical significance of unsatisfactory outcome and lack of endocervical component, determine ways that will improve collection technique.  

Webinar: Counseling Your HPV Positive Patients

Dr. Audrey P. Garrett provides insight on why HPV testing is an integral part of cervical cancer screening, how to discuss the meaning of an HPV+ patient and how to reassure patients when returning them to routine screening intervals.

Webinar: Anal Cytology: Who, why, how?

Dr. Joel M. Palefsky discusses anal cytology, the reasons to screen, how to screen, collect and process anal cytology and lastly how it performs as a screen for AIN.

Webinar: Clinical Utility of Genotyping

Dr. Michael A. Gold discusses genotyping and its significance in detecting cervical cancer.   

Webinar: The Complementary Nature of Pap and High-Risk HPV Testing

Dr. Randall K Gibb reviews advances in cervical cancer screening, relationship between HOV and cervical cancer, and reveals the guidance for pap and HPV testing.